NutriScan Sensitivity & Intolerance Test for Dogs • the Gold Standard
NutriScan is our novel patented diagnostic test based on saliva, which can reveal the latent or pre-clinical form of food sensitivity or food intolerance. Our test panels are for the most common allergens, and now include 22 allergens set up in 2 separate panels.
NutriScan should not be confused with other tests on serum or feces. They are not comparable.
Nutriscan is the basic initial diagnostic phase of assessing functional nutrition for an individual dog.
The presence (intermediate, medium or strong reactions) or absence (negative or weak reactions) of secretory (IgA) or primary (IgM) antibodies directed at specific food extracts is an indication of the dog’s changes in gene expression when faced with these reactive or compatible foods.
NutriScan thus depends upon the nutritional influences and factors that alter gene expression.· It represents a form of molecular dietary signature. NutriScan represents the “ functional nutrition” and ·“molecular dietary signature” of individual dogs.
NutriScan saliva screening diagnostics should be used annually by dog owners. This canine food sensitivity and intolerance diagnostic system tests saliva for food reactant antibodies in healthy dogs and those with known or suspected food intolerance. Dog owners can obtain the test kit from Hemopet or through their veterinarians. After following directions, adding saliva, the kit is sealed and sent to Hemopet for analysis.
If you have completed the Online Test Request Form, do not duplicate this by completing the Form insert in the kit. Rather place a copy of the completed OnlineTest Request Form in the box, when you return the box with sample to Hemopet.
Testing protocols are included for gluten and other primary dietary· food ingredient intolerance and sensitivity. Our testing for the 22 food antigens is structured in two panels of 11 antigens each. You can order either one or both panels electronically by clicking the Test Request Form on the left. You only need one kit and 2ml of sample will be sufficient for both panels.
PANEL 1: beef, corn, wheat, soy, milk (cow), lamb, venison, chicken, turkey, white fish, pork
PANEL 2: egg (hen), barley, millet, oatmeal, salmon, rabbit, rice, quinoa, potato, peanut (peanut butter), sweet potato
Our test measures IgA and IgM antibodies in saliva rather than IgE and IgG antibodies in serum or feces. NutriScan identifies true clinically relevant food sensitivities and intolerances that affect the animal on an ongoing and long term basis. Please see our FAQs for more details.
Our test is novel and patented and is not testing for food allergies, but rather tests for food sensitivities and intolerance. ·These are different body immune responses. Food allergy is a more immediate reaction mediated by production of IgE and IgG antibodies. Food sensitivity and intolerance, by contrast, measures a more delayed body response to offending foods by measuring production of IgA and IgM antibodies primarily in mucosal secretions from the bowel.
Since starting the NutriScan clinical testing in May 2011, I have personally compiled and analyzed 566 sequential canine case samples plus 29 other canine controls in preparation for formal refereed publication. This analysis compared results from 208 healthy control dogs, 289 suspected food intolerant dogs and 98 proven food intolerant dogs and unequivocally showed a progressive increase in the reactivities measured in each group, respectively. Statistically significant differences were found, as would be expected based on the clinical classification of these three case cohorts. These data clearly affirmed the validation of our results and the clinical utility of the test. As of April 2012 we have tested 1730 samples, and these results support and expand the detailed analysis of 566 cases initially analyzed.
As with any new testing, there will be skeptics. This is especially when the existing serum-based food “allergy” testing is well-recognized to be fraught with errors both in the test systems used and their clinical applicability to human (or animal) patients.